These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8042819)

  • 41. Pulmonary thromboembolism with massive vaginal bleeding due to thrombolytic therapy.
    Ekim N; Kokturk N; Yegin D; Kokturk O; Habesoglu MA
    Respirology; 2003 Jun; 8(2):246-8. PubMed ID: 12753544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful thrombolytic therapy for massive pulmonary embolism.
    Onuigbo M; Cuffy-Hallam M; Mangano A; Schwartz M; Alikhan M
    South Med J; 2000 Mar; 93(3):327-9. PubMed ID: 10728526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thrombolytic therapy in acute pulmonary embolism.
    Tapson VF
    Curr Opin Cardiol; 2012 Nov; 27(6):585-91. PubMed ID: 23075820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of major hemorrhage following fibrinolysis for acute pulmonary embolism.
    Fiumara K; Kucher N; Fanikos J; Goldhaber SZ
    Am J Cardiol; 2006 Jan; 97(1):127-9. PubMed ID: 16377297
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current Controversies in Thrombolytic Use in Acute Pulmonary Embolism.
    Long B; Koyfman A
    J Emerg Med; 2016 Jul; 51(1):37-44. PubMed ID: 27071316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute pulmonary embolism treated with tissue plasminogen activator.
    Goldhaber SZ; Vaughan DE; Markis JE; Selwyn AP; Meyerovitz MF; Loscalzo J; Kim DS; Kessler CM; Dawley DL; Sharma GV
    Lancet; 1986 Oct; 2(8512):886-9. PubMed ID: 2876327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulmonary embolism: segmental appearance of perfusion lung scan defects correlates with successful response to thrombolytic therapy.
    Parker JA; Nagel JS; Drum DE; Tumeh SS; Goldhaber SZ
    Radiology; 1990 Feb; 174(2):483-6. PubMed ID: 2104990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thrombolysis or heparin therapy in massive pulmonary embolism with right ventricular dilation: results from a 128-patient monocenter registry.
    Hamel E; Pacouret G; Vincentelli D; Forissier JF; Peycher P; Pottier JM; Charbonnier B
    Chest; 2001 Jul; 120(1):120-5. PubMed ID: 11451826
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hemodynamic impact of thrombolytic therapy in acute pulmonary thromboembolism].
    Baruzzi AC; Knobel E; Cirenza C; Smith MR; Barbas CS; Fernandes Júnior CJ; Akamine N
    Arq Bras Cardiol; 1995 Jun; 64(6):515-20. PubMed ID: 8561669
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pulmonary Embolism in 2017: How We Got Here and Where Are We Going?
    Merli GJ
    Tech Vasc Interv Radiol; 2017 Sep; 20(3):128-134. PubMed ID: 29029706
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Thrombolysis during cardio-pulmonary resuscitation].
    Wetsch WA; Spöhr F; Teschendorf P; Böttiger BW; Padosch SA
    Dtsch Med Wochenschr; 2010 Oct; 135(40):1983-8. PubMed ID: 20922642
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacoepidemiology of bleeding events after use of r-alteplase or streptokinase in acute myocardial infarction.
    McLeod DC; Coln WG; Thayer CF; Perfetto EM; Hartzema AG
    Ann Pharmacother; 1993; 27(7-8):956-62. PubMed ID: 8364282
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anuria due to acute bilateral renal vein occlusion after thrombolysis for pulmonary embolism.
    Zakynthinos E; Douka E; Daniil Z; Konstantinidis K; Markaki V; Zakynthinos S
    Int J Cardiol; 2005 May; 101(1):163-6. PubMed ID: 15860405
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systemic Thrombolysis for Pulmonary Embolism: Who and How.
    Tapson VF; Friedman O
    Tech Vasc Interv Radiol; 2017 Sep; 20(3):162-174. PubMed ID: 29029710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombolytic therapy for massive pulmonary embolism in a patient with a known intracranial tumor.
    Han S; Chaya C; Hoo GW
    J Intensive Care Med; 2006; 21(4):240-5. PubMed ID: 16855059
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Practice patterns and complication rates of thrombolysis for pulmonary embolism.
    Bradford MA; Lindenauer PK; Walkey AJ
    J Thromb Thrombolysis; 2016 Oct; 42(3):313-21. PubMed ID: 26961258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
    Skeik N; Gits CC; Ehrenwald E; Cragg AH
    Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thrombolytic therapy for pulmonary embolism.
    Dong B; Jirong Y; Liu G; Wang Q; Wu T
    Cochrane Database Syst Rev; 2006 Apr; (2):CD004437. PubMed ID: 16625603
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intracranial hemorrhage in a patient with sub-massive pulmonary embolism treated with EkoSonic endovascular system directed thrombolysis.
    Ganatra S; Majithia A; Yeh YE; Levy MS
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):476-479. PubMed ID: 28398633
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systemic Thrombolytic Therapy and Catheter-Directed Fragmentation with Local Thrombolytic Therapy in Patients with Pulmonary Embolism.
    Klevanets J; Starodubtsev V; Ignatenko P; Voroshilina O; Ruzankin P; Karpenko A
    Ann Vasc Surg; 2017 Nov; 45():98-105. PubMed ID: 28501664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.